» Articles » PMID: 9062895

Hepatic Calcium-binding Protein Regucalcin Concentration is Decreased by Streptozotocin-diabetic State and Ethanol Ingestion in Rats

Overview
Publisher Springer
Specialty Biochemistry
Date 1997 Mar 1
PMID 9062895
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The alteration in calcium-binding protein regucalcin in the liver and serum of rats with streptozotocin (STZ)-diabetic state or ethanol ingestion was investigated. STZ (6.0 mg/100 g body weight) was subcutaneously administered in rats, and 1 or 3 weeks later they were sacrificed by bleeding. Liver regucalcin mRNA levels were not clearly altered by the diabetic state, as evidenced by Northern blotting using regucalcin cDNA (0.9 kb of open reading frame). Based on enzyme-linked immunoadsorbent assay (ELISA) with rabbit-anti-regucalcin IgG, hepatic regucalcin concentration was decreased about 50% of control levels by STZ treatment. However, serum regucalcin concentration was not significantly altered by STZ treatment. Meanwhile, when rats ingested ethanol (10 and 30%) in the drinking water for 2 weeks, liver regucalcin mRNA levels were clearly increased, although hepatic regucalcin concentration was significantly decreased. Serum regucalcin concentration was not appreciably altered. Serum transaminases (GOT and GPT) activities were significantly increased at 1 or 3 weeks after STZ administration in rats, while their activities were not altered by ethanol ingestion. The present study demonstrates that hepatic regucalcin concentration is decreased independent of mRNA expression in the STZ-diabetes and during ethanol ingestion in rats.

Citing Articles

Hepatic proteomic analysis revealed altered metabolic pathways in insulin resistant Akt1(+/-)/Akt2(-/-) mice.

Pedersen B, Wang W, Taylor J, Khattab O, Chen Y, Edwards R Metabolism. 2015; 64(12):1694-703.

PMID: 26455965 PMC: 4641788. DOI: 10.1016/j.metabol.2015.09.008.


Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy.

Yamaguchi M J Cancer Res Clin Oncol. 2014; 141(8):1333-41.

PMID: 25230901 DOI: 10.1007/s00432-014-1831-z.


Comparative Proteomics Study of Streptozotocin-induced Diabetic Nephropathy in Rats Kidneys Transfected with Adenovirus-mediated Fibromodulin Gene.

Maleki A, Ramazani A, Foroutan M, Biglari A, Ranjzad P, Mellati A Avicenna J Med Biotechnol. 2014; 6(2):104-12.

PMID: 24834312 PMC: 4009092.


Regucalcin as a potential biomarker for metabolic and neuronal diseases.

Yamaguchi M Mol Cell Biochem. 2014; 391(1-2):157-66.

PMID: 24599745 DOI: 10.1007/s11010-014-1998-2.


The transcriptional regulation of regucalcin gene expression.

Yamaguchi M Mol Cell Biochem. 2010; 346(1-2):147-71.

PMID: 20936536 DOI: 10.1007/s11010-010-0601-8.


References
1.
Shimokawa N, Matsuda Y, Yamaguchi M . Genomic cloning and chromosomal assignment of rat regucalcin gene. Mol Cell Biochem. 1995; 151(2):157-63. DOI: 10.1007/BF01322338. View

2.
Yamaguchi M, Oishi K, Isogai M . Expression of hepatic calcium-binding protein regucalcin mRNA is elevated by refeeding of fasted rats: involvement of glucose, insulin and calcium as stimulating factors. Mol Cell Biochem. 1995; 142(1):35-41. DOI: 10.1007/BF00928911. View

3.
Yamaguchi M, Tai H . Inhibitory effect of calcium-binding protein regucalcin on Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase activity in rat liver cytosol. Mol Cell Biochem. 1991; 106(1):25-30. DOI: 10.1007/BF00231185. View

4.
Mori S, Yamaguchi M . Hepatic calcium-binding protein regucalcin decreases Ca2+/calmodulin-dependent protein kinase activity in rat liver cytosol. Chem Pharm Bull (Tokyo). 1990; 38(8):2216-8. DOI: 10.1248/cpb.38.2216. View

5.
Hoek J, Thomas A, Rubin R, Rubin E . Ethanol-induced mobilization of calcium by activation of phosphoinositide-specific phospholipase C in intact hepatocytes. J Biol Chem. 1987; 262(2):682-91. View